Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft CompositionArwen Stikvoort, Ahmed Gaballa, Martin Solders, et al.
Haematologica|September 24, 2016
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationJohan Törlén, Olle Ringdén, Karin Garming-Legert, et al.
Haematologica|September 24, 2013
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationMichael Uhlin, Helena Wikell, Mikael Sundin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host DiseaseBehnam Sadeghi, Mats Remberger, Britt Gustafsson, et al.
Clinical Chemistry and Laboratory Medicine|January 19, 2023
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantationIvan Pasic, Annie H Ren, Ram Vasudevan Nampoothiri, et al.
Oncotarget|September 27, 2017
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissueEmelie Rådestad, Lars Egevad, Carl Jorns, et al.
Journal for Immunotherapy of Cancer|February 6, 2023
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer modelsEsther Schoutrop, Thomas Poiret, Ibrahim El-Serafi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 17, 2026
Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical UtilitySergio Rodriguez-Rodriguez, Ayman Sayyed, Swe Mar Linn, et al.
Annals of Hematology|May 9, 2020
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationIvan Pasic, Jeffrey H Lipton, Dennis D Kim, et al.
Annals of Hematology|January 8, 2021
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin levelWarren Fingrut, Arjun Law, Wilson Lam, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft CompositionArwen Stikvoort, Ahmed Gaballa, Martin Solders, et al.
Haematologica|September 24, 2016
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationJohan Törlén, Olle Ringdén, Karin Garming-Legert, et al.
Haematologica|September 24, 2013
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationMichael Uhlin, Helena Wikell, Mikael Sundin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host DiseaseBehnam Sadeghi, Mats Remberger, Britt Gustafsson, et al.
Clinical Chemistry and Laboratory Medicine|January 19, 2023
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantationIvan Pasic, Annie H Ren, Ram Vasudevan Nampoothiri, et al.
Oncotarget|September 27, 2017
Characterization of infiltrating lymphocytes in human benign and malignant prostate tissueEmelie Rådestad, Lars Egevad, Carl Jorns, et al.
Journal for Immunotherapy of Cancer|February 6, 2023
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer modelsEsther Schoutrop, Thomas Poiret, Ibrahim El-Serafi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 17, 2026
Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical UtilitySergio Rodriguez-Rodriguez, Ayman Sayyed, Swe Mar Linn, et al.
Annals of Hematology|May 9, 2020
Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantationIvan Pasic, Jeffrey H Lipton, Dennis D Kim, et al.
Annals of Hematology|January 8, 2021
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin levelWarren Fingrut, Arjun Law, Wilson Lam, et al.
Pageof 26